The future of stem cells: Should we keep the “stem” and skip the “cells”?

Journal of Thoracic and Cardiovascular Surgery

Volumn 152, Issue 2, 2016, Pages 345-349

  Menasché, Philippe ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

biomaterials; heart failure; paracrine signaling effects by; stem cells

Indexed keywords

BETA FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BIOMIMETIC MATERIAL; COLLAGEN; FIBROBLAST GROWTH FACTOR; GELATIN; INTERLEUKIN 10; SCATTER FACTOR; SOMATOMEDIN; UNCLASSIFIED DRUG; CARDIOVASCULAR AGENT; DRUG CARRIER; FOLLISTATIN RELATED PROTEIN;

ARRHYTHMOGENESIS; CARDIAC MUSCLE; CARDIAC STEM CELL; EDITORIAL; ELECTROSPINNING; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; HYDROGEL; LIMB ISCHEMIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; ANIMAL; CONVALESCENCE; HEART DISEASE; MASS COMMUNICATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL; TREATMENT OUTCOME; TRENDS;

ANIMALS; CARDIOVASCULAR AGENTS; DIFFUSION OF INNOVATION; DRUG CARRIERS; FOLLISTATIN-RELATED PROTEINS; HEART DISEASES; HUMANS; MYOCARDIUM; PHENOTYPE; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

EID: 84961848403     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2016.02.058     Document Type: Editorial

References (26)

1. 1 Wei, K., Serpooshan, V., Hurtado, C., Diez-Cuñado, M., Zhao, M., Maruyama, S., et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature 525 (2015), 479–485.
2. 2 Masters, M., Riley, P.R., The epicardium signals the way towards heart regeneration. Stem Cell Res 13:3 Pt B (2014), 683–692.
3. 3 Canseco, D.C., Kimura, W., Garg, S., Mukherjee, S., Bhattacharya, S., Abdisalaam, S., et al. Human ventricular unloading induces cardiomyocyte proliferation. J Am Coll Cardiol 65 (2015), 892–900.
4. 4 Garbern, J.C., Lee, R.T., Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 12 (2013), 689–698.
5. 5 Timmers, L., Lim, S.K., Hoefer, I.E., Arslan, F., Lai, R.C., van Oorschot, A.A., et al. Mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6 (2011), 206–214.
6. 6 Hynes, B., Kumar, A.H., O'Sullivan, J., Klein Buneker, C., Leblond, A.L., Weiss, S., et al. Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1. Eur Heart J 34 (2013), 782–789.
7. 7 Tseliou, E., Fouad, J., Reich, H., Slipczuk, L., de Couto, G., Aminzadeh, M., et al. Fibroblasts rendered antifibrotic, antiapoptotic, and angiogenic by priming with cardiosphere-derived extracellular membrane vesicles. J Am Coll Cardiol 66 (2015), 599–611.
8. 8 Cervio, E., Barile, L., Moccetti, T., Vassalli, G., Exosomes for intramyocardial intercellular communication. Stem Cells Int, 2015, 2015, 482171.
9. 9 Kervadec, A., Bellamy, V., El Harane, N., Arakélian, L., Vanneaux, V., Cacciapuoti, I., et al. Cardiovascular progenitor–derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. J Heart Lung Transplant 35 (2016), 795–807.
10. 10 Tallawi, M., Rosellini, E., Barbani, N., Cascone, M.G., Rai, R., Saint-Pierre, G., et al. Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface, 12, 2015, 20150254.
11. 11 Bhana, B., Iyer, R.K., Chen, W.L., Zhao, R., Sider, K.L., Likhitpanichkul, M., et al. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng 105 (2010), 1148–1160.
12. 12 Atluri, P., Trubelja, A., Fairman, A.S., Hsiao, P., MacArthur, J.W., Cohen, J.E., et al. Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct. Circulation 128:11 Suppl 1 (2013), S95–S104.
13. 13 Holladay, C.A., Duffy, A.M., Chen, X., Sefton, M.V., O'Brien, T.D., Pandit, A.S., Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold. Biomaterials 33 (2012), 1303–1314.
14. 14 Savi, M., Bocchi, L., Fiumana, E., Karam, J.P., Frati, C., Bonafé, F., et al. Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats. J Biomed Mater Res A 103 (2015), 3012–3025.
15. 15 Song, T.H., Jang, J., Choi, Y.J., Shim, J.H., Cho, D.W., 3D-printed drug/cell carrier enabling effective release of cyclosporin A for xenogeneic cell-based therapy. Cell Transplant 24 (2015), 2513–2525.
16. 16 Vernon, R.B., Preisinger, A., Gooden, M.D., D'Amico, L.A., Yue, B.B., Bollyky, P.L., et al. Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor. Cell Transplant 21 (2012), 2099–2110.
17. 17 Hsieh, P.C., Davis, M.E., Gannon, J., MacGillivray, C., Lee, R.T., Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116 (2006), 237–248.
18. 18 Segers, V.F., Lee, R.T., Biomaterials to enhance stem cell function in the heart. Circ Res 109 (2011), 910–922.
19. 19 Formiga, F.R., Pelacho, B., Garbayo, E., Imbuluzqueta, I., Díaz-Herráez, P., Abizanda, G., et al. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration. J Contr Release 173 (2014), 132–139.
20. 20 Projahn, D., Simsekyilmaz, S., Singh, S., Kanzler, I., Kramp, B.K., Langer, M., et al. Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction. J Cell Mol Med 18 (2014), 790–800.
21. 21 Kumagai, M., Marui, A., Tabata, Y., Takeda, T., Yamamoto, M., Yonezawa, A., et al. Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia. Heart Vessels, April 11, 2015 [Epub ahead of print].
22. 22 Hamdi, H., Furuta, A., Bellamy, V., Bel, A., Puymirat, E., Peyrard, S., et al. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 87 (2009), 1196–1203.
23. 23 Fathi, E., Nassiri, S.M., Atyabi, N., Ahmadi, S.H., Imani, M., Farahzadi, R., et al. Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myocardial infarction. J Tissue Eng Regen Med 7 (2013), 697–707.
24. 24 Tous, E., Ifkovits, J.L., Koomalsingh, K.J., Shuto, T., Soeda, T., Kondo, N., et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. Biomacromolecules 12 (2011), 4127–4135.
25. 25 Mann, D.L., Lee, R.J., Coats, A.J., Neagoe, G., Dragomir, D., Pusineri, E., et al. One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure. Eur J Heart Fail, November 11, 2015 [Epub ahead of print].
26. 26 Nelson, D.M., Ma, Z., Fujimoto, K.L., Hashizume, R., Wagner, W.R., Intra-myocardial biomaterial injection therapy in the treatment of heart failure: materials, outcomes and challenges. Acta Biomater 7 (2011), 1–15.